NLRB v. Kentucky River Community Care, Inc.

Columbia Care Announces Closing of US$185 Million Private Placement of 9.50% Senior-Secured First-Lien Notes

Retrieved on: 
Thursday, February 3, 2022
Alternative Medicine, Health, Securities Act of 1933, Public expenditure, CEO, Patient, CSE, NLRB v. Kentucky River Community Care, Inc., Sale, Note, Amber, Goal, 777, Offering, Bookrunner, NEO, Person, Adult, Regulation, Oil, Company, News, FSE, Disclosure, Seed, Tablet, Security (finance), Cannabist Kansai, EU

The 2026 Notes are senior secured obligations of the Company and were issued at 100% of face value.

Key Points: 
  • The 2026 Notes are senior secured obligations of the Company and were issued at 100% of face value.
  • The 2026 Notes accrue interest payable semi-annually in arrears and mature on February 3, 2026, unless earlier redeemed or repurchased.
  • Columbia Care operates 131 facilities including 99 dispensaries and 32 cultivation and manufacturing facilities, including those under development.
  • Columbia Care undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable law.

Columbia Care to Report Fourth Quarter and Full Year 2021 Results on March 15, 2022

Retrieved on: 
Monday, January 31, 2022
Alternative Medicine, Retail, Health, Agriculture, Natural Resources, Specialty, Pharmaceutical, EST, CSE, NLRB v. Kentucky River Community Care, Inc., Amber, Telephone, 777, NEO, Investor relations, Oil, Company, FSE, Seed, Tablet, Pharmaceutical industry, Mobile phone, Cannabist Kansai, EU

Columbia Care Inc. (NEO: CCHW) (CSE: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (Columbia Care or the Company) today announced that it will report its financial results for the fourth quarter and full year ended December 31, 2021 after US financial markets close on Tuesday, March 15, 2022.

Key Points: 
  • Columbia Care Inc. (NEO: CCHW) (CSE: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (Columbia Care or the Company) today announced that it will report its financial results for the fourth quarter and full year ended December 31, 2021 after US financial markets close on Tuesday, March 15, 2022.
  • Following the release of financial results, Company management will conduct a conference call at 5:00 p.m. EST to discuss financial and operating results for the fourth quarter and full year of 2021.
  • Columbia Care operates 131 facilities including 99 dispensaries and 32 cultivation and manufacturing facilities, including those under development.
  • In 2021, the company launched Cannabist, its new retail brand, creating a national dispensary network that leverages proprietary technology platforms.

Columbia Care Announces Receipt of Noteholder Consent for Amendment to Trust Indenture to Increase Debt Capacity

Retrieved on: 
Friday, January 21, 2022
Medical Supplies, Finance, Professional Services, Biotechnology, Alternative Medicine, Health, Pharmaceutical, Agriculture, Natural Resources, Amber, SEDAR, FSE, 777, Solicitation, Tablet, Oil, NLRB v. Kentucky River Community Care, Inc., Company, Seed, CSE, Compliance, NEO, Risk, Security (finance), EU, Cannabist Kansai, Indenture, Note

The key amendment significantly increases the Companys borrowing capacity to support growth initiatives.

Key Points: 
  • The key amendment significantly increases the Companys borrowing capacity to support growth initiatives.
  • The proposed Indenture amendments are described in the consent solicitation statement (Solicitation Statement), which was mailed to Noteholders on or about January 10, 2022 and was filed on SEDAR.
  • A supplemental indenture giving effect to the Indenture amendments will be filed on SEDAR following its execution.
  • Columbia Care operates 131 facilities including 99 dispensaries and 32 cultivation and manufacturing facilities, including those under development.

Columbia Care Welcomes Derek Watson as Chief Financial Officer

Retrieved on: 
Tuesday, January 18, 2022
Other Retail, Alternative Medicine, Manufacturing, Professional Services, Health, Specialty, Agriculture, Natural Resources, Other Manufacturing, Retail, Finance, Board, Amber, SEDAR, The Culinary Institute of America, FSE, Treasury, ICAEW, 777, Kingston University, Accounting, Chief commercial officer, Tablet, KPMG, Partner, Schindler Elevator Corporation, MBA, Growth, CEO, Strategic Initiative for Women in the Horn of Africa, Starr Restaurants, Leadership, Pakistan Institute of Public Finance Accountants, Industry, Oil, NLRB v. Kentucky River Community Care, Inc., Information technology, Culinary Institute, Company, Seed, CFO, CSE, Columbia University, Risk management, Taste, Fly, NEO, Risk, Investment, Management, EU, Cannabist Kansai

Columbia Care Inc. (NEO: CCHW) (CSE: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (Columbia Care or the Company), one of the largest and most experienced cultivators, manufacturers and providers of medical and adult-use cannabis products in the United States, has hired Derek Watson as Chief Financial Officer.

Key Points: 
  • Columbia Care Inc. (NEO: CCHW) (CSE: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (Columbia Care or the Company), one of the largest and most experienced cultivators, manufacturers and providers of medical and adult-use cannabis products in the United States, has hired Derek Watson as Chief Financial Officer.
  • Prior to joining Columbia Care, Derek served as the Chief Financial and Commercial Officer at Tastes on the Fly, a private equity-backed, national consumer retail company based in California.
  • He has also held Chief Financial Officer roles at two other consumer companies, Starr Restaurants and Samba Brands, and as Chief Financial Officer and Vice President of Strategic Initiatives at Schindler Elevator, the U.S. subsidiary of Schindler Holding AG (SCHN.SW).
  • Columbia Care operates 131 facilities including 99 dispensaries and 32 cultivation and manufacturing facilities, including those under development.

Columbia Care Announces Commencement of Noteholder Consent Solicitation to Increase Debt Capacity

Retrieved on: 
Thursday, January 6, 2022
Agriculture, Natural Resources, Alternative Medicine, Other Retail, Other Manufacturing, Health, Manufacturing, Retail, Odyssey, Amber, Seed, FSE, 777, NLRB v. Kentucky River Community Care, Inc., Company, Tablet, Telephone, Oil, CSE, Risk, SEDAR, Compliance, NEO, Solicitation, Security (finance), Cannabist Kansai, EU, Note

The Company may extend the Consent Deadline for such period or periods as it may determine in its sole discretion.

Key Points: 
  • The Company may extend the Consent Deadline for such period or periods as it may determine in its sole discretion.
  • Prior to the commencement of the Consent Solicitation, the Company entered into support agreements with Noteholders holding a majority of the outstanding principal amount of the Notes.
  • Pursuant to the support agreements, such holders of Notes have agreed to deliver consent to the proposed amendments prior to the Consent Deadline.
  • As a result, the Company anticipates completion of the Consent Solicitation as of the Consent Deadline.

Columbia Care Opens its 80th Dispensary with New Cannabist Location in Virginia Beach

Retrieved on: 
Monday, January 3, 2022
Other Manufacturing, Other Retail, Tobacco, Specialty, Manufacturing, Alternative Medicine, Health, Agriculture, Retail, Natural Resources, Amber, NEO, Board, SEDAR, Seed, Company, Commonwealth, NLRB v. Kentucky River Community Care, Inc., Risk, Medicine, FSE, Adult, Patient, Oil, CSE, 777, National Association of Boards of Pharmacy, Tablet, Hospital, Cannabist Kansai, Pharmacy, EU

Virginias demand for high quality cannabis continues to grow, and were here to answer the call with our new Virginia Beach dispensary to serve the most populous city in the state, said Jesse Channon, Chief Growth Officer of Columbia Care.

Key Points: 
  • Virginias demand for high quality cannabis continues to grow, and were here to answer the call with our new Virginia Beach dispensary to serve the most populous city in the state, said Jesse Channon, Chief Growth Officer of Columbia Care.
  • As conversations around adult use in Virginia progress, we are eager and excited to make cannabis more accessible, and to expand our transformation to Cannabist across the country.
  • The new dispensary marks Columbia Cares fourth location in Virginia, following its recently announced gLeaf opening in Glen Allen, a Richmond suburb.
  • In 2021, the company launched Cannabist, its new retail brand, creating a national dispensary network that leverages proprietary technology platforms.

 Columbia Care Launches the UK’s Broadest Portfolio of Doseable Medical Cannabis Extract Vaporizer Pens; First Company to Manufacture Extract Vaporization Products in the UK

Retrieved on: 
Tuesday, December 14, 2021
Other Manufacturing, Other Retail, Tobacco, Specialty, Manufacturing, Alternative Medicine, Health, Agriculture, Retail, Natural Resources, Amber, Tablet, Pharmacy, Sleep, Cannabis, Company, Pain, Seed, SEDAR, Home Office, 777, Risk, FSE, Chronic pain, CEO, MHRA, Oil, Patient, Fear, National Institute of Design, Health care, NLRB v. Kentucky River Community Care, Inc., IMPACT, IP, NEO, CSE, Cannabinoid, Pharmaceutical industry, Cannabist Kansai, EU, Columbia Care, Columbia Care International, COLUMBIA CARE, COLUMBIA CARE INTERNATIONAL

This portfolio of products offers clinicians and patients in the UK the broadest range of medicinal cannabis products with the capability to target different onset periods and duration of effect.

Key Points: 
  • This portfolio of products offers clinicians and patients in the UK the broadest range of medicinal cannabis products with the capability to target different onset periods and duration of effect.
  • Columbia Cares mission has always been to provide patients with access to the highest quality, safest medicinal cannabis products available.
  • Columbia Care International is part of Columbia Care and is currently focused on serving the medical cannabis markets in the UK and Germany and the UK hemp-derived wellness market.
  • In early 2021, the Company was the first to launch a solid-fill medical cannabis capsule in the UK.

iAnthus Provides Update on the Florida Regulatory Approval for the Recapitalization Transaction Change of Ownership

Retrieved on: 
Thursday, December 9, 2021
SEC, CSE, Florida Rules of Civil Procedure, News, Maryland Office of Administrative Hearings, Uncertainty, Petition, ISDA Master Agreement, Infection, Annual report, Acquisition, McCrory, Forward-looking statement, Florida Statutes, MPX, Patient, Florida Administrative Code, NLRB v. Kentucky River Community Care, Inc., Securities & Exchange Commission of Pakistan, Multimedia, Fear, Formalized Administrative Notation (FAN), Medical cannabis, Florida Division of Alcoholic Beverages and Tobacco, The Company, Pandemic, LLC, U.S. Securities and Exchange Commission, Regulation, Review, CRC, Florida Department, View, RSA, Canadian Securities Exchange, COVID-19, Time, Travel, Agreement, Bank, Security (finance)

NEW YORKand TORONTO, Dec. 9, 2021 /PRNewswire/ -iAnthus Capital Holdings, Inc. ("iAnthus" or the "Company") (CSE: IAN) (OTCPK: ITHUF), which owns, operates and partners with regulated cannabis operations across the United States, provides an update with respect to the Company's previously announced recapitalization transaction (the "Recapitalization Transaction").

Key Points: 
  • NEW YORKand TORONTO, Dec. 9, 2021 /PRNewswire/ -iAnthus Capital Holdings, Inc. ("iAnthus" or the "Company") (CSE: IAN) (OTCPK: ITHUF), which owns, operates and partners with regulated cannabis operations across the United States, provides an update with respect to the Company's previously announced recapitalization transaction (the "Recapitalization Transaction").
  • As previously disclosed, securityholder approval and Court approval were two of the primary conditions for closing the Recapitalization Transaction, both of which conditions have been satisfied.
  • The closing of the Recapitalization Transaction remains subject to certain closing conditions as set forth in the Restructuring Support Agreement dated July 10, 2020, as amended (the "RSA").
  • As disclosed in the Company's news release dated November 4, 2021, regulatory approvals in Massachusetts, New York and Maryland1 necessary to close the Recapitalization Transaction were outstanding.

Columbia Care Transforms Florida Footprint to New Award-Winning Cannabist Retail Experience

Retrieved on: 
Wednesday, December 8, 2021
Other Manufacturing, Other Retail, Tobacco, Specialty, Manufacturing, Alternative Medicine, Health, Agriculture, Retail, Natural Resources, SEDAR, Company, NEO, 777, CSE, Technology, Amber, Seed, Florida Department, NLRB v. Kentucky River Community Care, Inc., Patient, CEO, Industry, Oil, Tablet, Capsule, Florida Department of Veterans Affairs, Solution, Risk, FSE, Drug

This is our first market-wide Cannabist launch and represents a critical step in Columbia Cares evolution, said Nicholas Vita, CEO, Columbia Care.

Key Points: 
  • This is our first market-wide Cannabist launch and represents a critical step in Columbia Cares evolution, said Nicholas Vita, CEO, Columbia Care.
  • We look forward to bringing Cannabist to even more customers and patients across the country in 2022 as we expand throughout our national retail footprint.
  • Weve seen a tremendous response to Cannabist transitions in other markets and look forward to sharing Cannabist with Florida patients.
  • In September 2021, Columbia Care received approval from the Florida Department of Healths Office of Medical Marijuana Use (OMMU) to operate as Cannabist.

Columbia Care Celebrates Inclusion in MSCI Canada Small Cap Index

Retrieved on: 
Tuesday, November 30, 2021
Biotechnology, Natural Resources, Pharmaceutical, Other Retail, Medical Supplies, Health, Other Natural Resources, Retail, Amber, Seed, SEDAR, Risk, Company, CSE, Oil, NEO Exchange, 777, Tablet, NLRB v. Kentucky River Community Care, Inc., FSE, NEO

Columbia Care Inc. (NEO: CCHW) (CSE: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (Columbia Care or the Company), one of the largest and most experienced cultivators, manufacturers and providers of cannabis products in the U.S., announced that MSCI Inc. (MSCI), a leading provider of critical decision support tools and services for the global investment community, has added Columbia Care to the MSCI Canada Small Cap Index, as of market close on November 30.

Key Points: 
  • Columbia Care Inc. (NEO: CCHW) (CSE: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (Columbia Care or the Company), one of the largest and most experienced cultivators, manufacturers and providers of cannabis products in the U.S., announced that MSCI Inc. (MSCI), a leading provider of critical decision support tools and services for the global investment community, has added Columbia Care to the MSCI Canada Small Cap Index, as of market close on November 30.
  • Columbia Care is the first and only U.S.-based cannabis company to be added to a major benchmarking index.
  • Our inclusion in MSCI index benchmarks is a testament to the quality, good governance and growth trajectory of Columbia Care, as well as our commitment to drive shareholder value, said Nicholas Vita, Chief Executive Officer of Columbia Care.
  • The MSCI Canada Small Cap Index is designed to measure the performance of the small cap segment of the Canada market.